Insulet
PODD
#1969
Rank
$10.15 B
Marketcap
$146.40
Share price
0.76%
Change (1 day)
-55.37%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): $5.94

According to Insulet's latest financial reports the company's current EPS (TTM) is $5.94. In 2024 the company made an earnings per share (EPS) of $5.98 an increase over its 2023 EPS that were of $2.95.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$5.94
2024$5.98102.71%
2023$2.954114.29%
2022$0.07000-69.57%
2021$0.23109.09%
2020$0.11-38.89%
2019$0.18200%
2018$0.06000-113.04%
2017-$0.46-9.8%
2016-$0.51-60.47%
2015-$1.2938.71%
2014-$0.9312.05%
2013-$0.83-23.15%
2012-$1.08-12.2%
2011-$1.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 12.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$2.70-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$4.08-31.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$30.89 420.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-$0.93-115.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
$1.20-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$2.59-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA